| P50 | author | Tebello Nyokong | Q21448010 |
| P2093 | author name string | Hubert van den Bergh | |
| | Norbert Lange | |
| | Nawal Sekkat | |
| P2860 | cites work | In vivo imaging of tumors with protease-activated near-infrared fluorescent probes | Q28141852 |
| | Molecular beacons: probes that fluoresce upon hybridization | Q28274024 |
| | A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs | Q28285226 |
| | Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates | Q28366253 |
| | Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine | Q28478461 |
| | Penetration enhancers | Q29544845 |
| | Polymeric micelles in anticancer therapy: targeting, imaging and triggered release | Q30478123 |
| | Photodynamic therapy and the development of metal-based photosensitisers | Q30493290 |
| | Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients | Q30634636 |
| | Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts | Q30649458 |
| | Pc 4 photodynamic therapy of U87-derived human glioma in the nude rat. | Q30785671 |
| | Photodynamic therapy (PDT) for lung cancers. | Q30830936 |
| | Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice | Q30871631 |
| | Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice | Q30947845 |
| | Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status | Q32108212 |
| | Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. | Q33187518 |
| | Experimental assessment of the capacities of use of photosense. Communication 2. Photodynamic therapy for epibulbar and choroid tumors | Q33226731 |
| | Intravenous repeated-dose toxicity study of ZnPcS2P2-based-photodynamic therapy in Wistar rats | Q33262327 |
| | Syntheses of Metal Phthalocyanines and Their Photoinactivations on Cancer Cells | Q74601407 |
| | In vitro and in vivo effects of photodynamic therapy on murine malignant melanoma | Q74601709 |
| | Cyclodextrin dimers as cleavable carriers of photodynamic sensitizers | Q77345547 |
| | Tetra-trifluoroethoxyl zinc phthalocyanine: potential photosensitizer for use in the photodynamic therapy of cancer | Q77363471 |
| | Metal complexes as photo- and radiosensitizers | Q77367176 |
| | Liposome-bound Zn (II)-phthalocyanine. Mechanisms for cellular uptake and photosensitization | Q77735942 |
| | Synthesis and in vitro photodynamic activity of mono-substituted amphiphilic zinc(II) phthalocyanines | Q79382716 |
| | Determination of proteins at nanogram levels by a resonance light-scattering technique with tetra-substituted sulphonated aluminum phthalocyanine | Q79748003 |
| | A set of highly water-soluble tetraethyleneglycol-substituted Zn(II) phthalocyanines: synthesis, photochemical and photophysical properties, interaction with plasma proteins and in vitro phototoxicity | Q82859799 |
| | Iontophoretic transport of zinc phthalocyanine tetrasulfonic acid as a tool to improve drug topical delivery | Q83843505 |
| | Preparation and photodynamic activities of silicon(IV) phthalocyanines substituted with permethylated β-cyclodextrins | Q84153689 |
| | Unsymmetrical β-cyclodextrin-conjugated silicon(IV) phthalocyanines as highly potent photosensitisers for photodynamic therapy | Q84617245 |
| | Photodynamic effects of a novel series of silicon(IV) phthalocyanines against human colon adenocarcinoma cells | Q87421039 |
| | Biological activities of phthalocyanines--III. Photoinactivation of V-79 Chinese hamster cells by tetrasulfophthalocyanines | Q93676881 |
| | In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy | Q95721170 |
| | Photodynamic activity of BAM-SiPc, an unsymmetrical bisamino silicon(IV) phthalocyanine, in tumour-bearing nude mice. | Q39542782 |
| | Delivery of the photosensitizer Pc 4 in PEG-PCL micelles for in vitro PDT studies | Q39766119 |
| | Photochemical internalization as an adjunct to marginal surgery in a human sarcoma model | Q39843479 |
| | Effects of the number and position of the substituents on the in vitro photodynamic activities of glucosylated zinc(II) phthalocyanines | Q39864552 |
| | Highly photocytotoxic 1,4-dipegylated zinc(II) phthalocyanines. Effects of the chain length on the in vitro photodynamic activities. | Q39911301 |
| | Glycosylated zinc(II) phthalocyanines as efficient photosensitisers for photodynamic therapy. Synthesis, photophysical properties and in vitro photodynamic activity | Q39975073 |
| | Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer | Q39989981 |
| | Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine-bombesin conjugate | Q40004339 |
| | Two-photon absorption cross-sections and time-resolved fluorescence imaging using porphyrin photosensitisers. | Q40089100 |
| | Polymeric photosensitizer prodrugs for photodynamic therapy | Q40103678 |
| | Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes | Q40137612 |
| | Highly photocytotoxic glucosylated silicon(IV) phthalocyanines. Effects of peripheral chloro substitution on the photophysical and photodynamic properties. | Q40152449 |
| | Synthesis and properties of cell-targeted Zn(II)-phthalocyanine-peptide conjugates. | Q40174430 |
| | Assembling a mixed phthalocyanine-porphyrin array in aqueous media through host-guest interactions. | Q40184308 |
| | BAM-SiPc, a novel agent for photodynamic therapy, induces apoptosis in human hepatocarcinoma HepG2 cells by a direct mitochondrial action. | Q40315595 |
| | The effect of Ge, Si and Sn phthalocyanine photosensitizers on cell proliferation and viability of human oesophageal carcinoma cells | Q40324060 |
| | High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanoparticles. | Q40370077 |
| | Synthesis and cellular studies of nonaggregated water-soluble phthalocyanines. | Q40457495 |
| | Synthesis and in vitro photodynamic activity of new hexadeca-carboxy phthalocyanines | Q40507320 |
| | Killing efficacy of a new silicon phthalocyanine in human melanoma cells treated with photodynamic therapy by early activation of mitochondrion-mediated apoptosis | Q40580803 |
| | Photodynamic therapy of human breast cancer xenografts lacking caspase-3. | Q40746691 |
| | The role of lipoproteins in the delivery of tumour-targeting photosensitizers | Q40773646 |
| | Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates | Q40907379 |
| | Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells | Q40920176 |
| | A comparative study of the cellular uptake and photodynamic efficacy of three novel zinc phthalocyanines of differing charge | Q40955955 |
| | Photosensitization of human skin cell lines by ATMPn (9-acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene) in vitro: mechanism of action | Q40960351 |
| | Aluminium phthalocyanine mediated photodynamic therapy in experimental malignant glioma. | Q40988640 |
| | Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy | Q41032674 |
| | Light scattering of human skin: a comparison between zinc (II)-phthalocyanine and photofrin II. | Q41047975 |
| | Syntheses and photodynamic activities of novel trisulfonated zinc phthalocyanine derivatives | Q41077068 |
| | Structure and biodistribution relationships of photodynamic sensitizers | Q41111962 |
| | The synthesis, photophysical and photobiological properties and in vitro structure-activity relationships of a set of silicon phthalocyanine PDT photosensitizers | Q41124199 |
| | Cytotoxic, nuclear, and growth inhibitory effects of photodynamic drugs on pancreatic carcinoma cells | Q41205192 |
| | Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitised tumour necrosis | Q41235155 |
| | Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy | Q41322837 |
| | Phthalocyanine photosensitizers for the treatment of brain tumours | Q41382582 |
| | Stereochemical factors in the transport and binding of photosensitizers in biological systems and in photodynamic therapy | Q41556938 |
| | Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. | Q41584678 |
| | Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine. | Q41725866 |
| | Photochemical internalisation of chemotherapy potentiates killing of multidrug-resistant breast and bladder cancer cells. | Q41847288 |
| | In-vitro and in-vivo evaluation of pH-responsive polymeric micelles in a photodynamic cancer therapy model | Q41920044 |
| | Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism | Q41924545 |
| | Photodynamic therapy of cottontail rabbit papillomavirus-induced papillomas in a severe combined immunodeficient mouse xenograft system | Q41932696 |
| | Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer | Q41980066 |
| | Phthalocyanine dimerization-based molecular beacons using near-IR fluorescence | Q42010878 |
| | Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitised liposomes directed to cells by monoclonal antibody in vitro | Q42020730 |
| | Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative | Q42109743 |
| | Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice | Q42279946 |
| | Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivat | Q42614127 |
| | In vitro resistance selection studies of RLP068/Cl, a new Zn(II) phthalocyanine suitable for antimicrobial photodynamic therapy. | Q42929756 |
| | Photodynamic activity of a glucoconjugated silicon(IV) phthalocyanine on human colon adenocarcinoma | Q43083520 |
| | Photophysics of zinc (II) phthalocyanine polymer and gel formulation | Q43160756 |
| | Water-soluble cationic gallium(III) and indium(III) phthalocyanines for photodynamic therapy | Q43190797 |
| | Synthesis of phthalocyanines-ALA conjugates: water-soluble compounds with low aggregation. | Q43278612 |
| | Chloroaluminum phthalocyanine tetrasulfonate delivered via acid-labile diplasmenylcholine-folate liposomes: intracellular localization and synergistic phototoxicity | Q43658872 |
| | Photosensitized and catalytic oxidation of DNA by metallophthalocyanine-oligonucleotide conjugates. | Q43741738 |
| | Photodynamic efficacy of water-soluble Si(IV) and Ge(IV) phthalocyanines towards Candida albicans planktonic and biofilm cultures | Q43991055 |
| | Chelation with metal is not essential for antitumor photodynamic activity of sulfonated phthalocyanines. | Q43997869 |
| | Photodynamic properties of amphiphilic derivatives of aluminum tetrasulfophthalocyanine | Q44113358 |
| | Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes | Q44124095 |
| | Asymmetrical, water-soluble phthalocyanine dyes for covalent labeling of oligonucleotides. | Q44222035 |
| | Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model | Q44223189 |
| | Distribution of metal-free sulfonated phthalocyanine in subcutaneously transplanted murine tumors. | Q44972325 |
| | New amphiphilic silicon(IV) phthalocyanines as efficient photosensitizers for photodynamic therapy: synthesis, photophysical properties, and in vitro photodynamic activities. | Q45062732 |
| | Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells. | Q45137105 |
| | Structure-photodynamic activity relationships of substituted zinc trisulfophthalocyanines | Q45228612 |
| | Photodynamic therapy of virus-associated precancer and early stages cancer of cervix uteri | Q45385422 |
| | PEGylation strategies for active targeting of PLA/PLGA nanoparticles | Q46267770 |
| | Near IR emitting isothiocyanato-substituted fluorophores: their synthesis and bioconjugation to monoclonal antibodies | Q46565334 |
| | Photophysicochemical consequences of bovine serum albumin binding to non-transition metal phthalocyanine sulfonates | Q46573269 |
| | Mechanism of photodynamic occlusion using liposomal Zn(II)-phtalocyanine | Q46601398 |
| | [Analysis of changes in the accumulation of the photosensitizer Photosens, its elimination kinetics and distribution in the tissues of the eye and eyelids in health and in some tumorous processes] | Q46720013 |
| | Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis | Q47790848 |
| | Experimental studies of the effects of ZnPcS2P2-based-photodynamic therapy on bone marrow purging. | Q50486504 |
| | Homogeneous detection of nucleic acids by transient-state polarized fluorescence. | Q50779868 |
| | Polyion complex micelles for photodynamic therapy: incorporation of dendritic photosensitizer excitable at long wavelength relevant to improved tissue-penetrating property. | Q51201504 |
| | Phthalocyanine-polyamine conjugates as highly efficient photosensitizers for photodynamic therapy. | Q51770486 |
| | Suspected anaphylactic reaction to Cremophor EL. | Q51875835 |
| | Photosensitising drugs - their potential in oncology. | Q52863288 |
| | Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. | Q52867335 |
| | ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. | Q55467832 |
| | Phthalocyanines and related complexes as electrocatalysts for the detection of nitric oxide | Q58840303 |
| | In vitro photodynamic therapy on melanoma cell lines with phthalocyanine | Q33263068 |
| | Photodynamic therapy and cancer: a brief sightseeing tour | Q33276646 |
| | High-field magnetic resonance imaging of the response of human prostate cancer to Pc 4-based photodynamic therapy in an animal model | Q33303889 |
| | Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes | Q33324540 |
| | Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin | Q33336105 |
| | Enhanced photodynamic cancer treatment by supramolecular nanocarriers charged with dendrimer phthalocyanine | Q33383673 |
| | Photocytotoxic efficacy of sulphonated species of aluminium phthalocyanine against cell monolayers, multicellular spheroids and in vivo tumours. | Q33421401 |
| | Photochemical internalization of bleomycin before external-beam radiotherapy improves locoregional control in a human sarcoma model | Q33491969 |
| | Monitoring interstitial m-THPC-PDT in vivo using fluorescence and reflectance spectroscopy. | Q33508614 |
| | Sunlight triggered photodynamic ultradeformable liposomes against Leishmania braziliensis are also leishmanicidal in the dark. | Q33667946 |
| | Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial | Q33796958 |
| | Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy | Q33915542 |
| | The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter | Q33937668 |
| | A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy. | Q33962996 |
| | Photodynamic therapy disinfection of carious tissue mediated by aluminum-chloride-phthalocyanine entrapped in cationic liposomes: an in vitro and clinical study | Q33978446 |
| | Facile synthesis of pegylated zinc(II) phthalocyanines via transesterification and their in vitro photodynamic activities | Q34000156 |
| | Cerebral edema following photodynamic therapy using endogenous and exogenous photosensitizers in normal brain | Q34050281 |
| | Photodynamic therapy for cancer | Q34194073 |
| | Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents | Q34201954 |
| | The present and future role of photodynamic therapy in cancer treatment | Q34337882 |
| | The history of photodetection and photodynamic therapy. | Q34449139 |
| | Metallo-phthalocyanine near-IR fluorophores: oligonucleotide conjugates and their applications in PCR assays | Q34508239 |
| | Laser-induced photodynamic therapy with aluminum phthalocyanine tetrasulfonate as the photosensitizer: differential phototoxicity in normal and malignant human cells in vitro | Q34514112 |
| | Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery | Q34656031 |
| | Glucose transporters: expression, regulation and cancer. | Q34747650 |
| | The role of apoptosis in response to photodynamic therapy: what, where, why, and how. | Q35092776 |
| | Bombesin-like peptides: candidates as diagnostic and therapeutic tools. | Q35100949 |
| | Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules | Q35600809 |
| | Polymeric micelles to deliver photosensitizers for photodynamic therapy | Q35620842 |
| | Photochemical internalisation in drug and gene delivery. | Q35620861 |
| | Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy | Q35633124 |
| | Photodynamic therapy of age-related macular degeneration: History and principles | Q35932469 |
| | Structural factors and mechanisms underlying the improved photodynamic cell killing with silicon phthalocyanine photosensitizers directed to lysosomes versus mitochondria | Q35955773 |
| | Biological activities of phthalocyanines--XVI. Tetrahydroxy- and tetraalkylhydroxy zinc phthalocyanines. Effect of alkyl chain length on in vitro and in vivo photodynamic activities | Q35976959 |
| | CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours | Q35978442 |
| | In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes | Q35978486 |
| | Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency | Q35981418 |
| | Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma | Q36027994 |
| | Selective necrosis of malignant gliomas in mice using photodynamic therapy | Q36028789 |
| | Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma | Q36081132 |
| | Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine | Q36136333 |
| | The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis | Q36252799 |
| | The photodynamic response of two rodent tumour models to four zinc (II)-substituted phthalocyanines | Q36292176 |
| | 5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives | Q36423131 |
| | Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis | Q36502053 |
| | Exploiting the enhanced permeability and retention effect for tumor targeting | Q36578875 |
| | Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin | Q36615900 |
| | Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study | Q36620119 |
| | Fluorescence imaging in vivo: recent advances | Q36711843 |
| | Apoptosis is an early event during phthalocyanine photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin | Q36834318 |
| | Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression | Q36861438 |
| | Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics | Q36862390 |
| | Targeted pharmaceutical nanocarriers for cancer therapy and imaging | Q36871933 |
| | Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles | Q37441462 |
| | Photochemical internalization (PCI) in cancer therapy: from bench towards bedside medicine. | Q37495033 |
| | On the cutting edge: protease-sensitive prodrugs for the delivery of photoactive compounds | Q37836419 |
| | Photosensitizers in clinical PDT. | Q38232376 |
| | Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy. | Q38282575 |
| | Strand displacement amplification--an isothermal, in vitro DNA amplification technique | Q38329444 |
| | Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles | Q38563687 |
| | Modulating the electronic properties of porphyrinoids: a voyage from the violet to the infrared regions of the electromagnetic spectrum. | Q38572550 |
| | Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy | Q39120026 |
| | Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy | Q39121108 |
| | Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro | Q39122815 |
| | Topical application of a first porphycene dye for photodynamic therapy--penetration studies in human perilesional skin and basal cell carcinoma | Q39444267 |
| | In vitro and in vivo targeted delivery of photosensitizers to the tumor cells for enhanced photodynamic effects. | Q39449513 |
| | Disulfide crosslinked polyion complex micelles encapsulating dendrimer phthalocyanine directed to improved efficiency of photodynamic therapy | Q39518288 |
| | Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo | Q39521324 |
| | Excited triplet state photophysics of the sulphonated aluminium phthalocyanines bound to human serum albumin | Q63546731 |
| | The distribution of the tumour photosensitizers Zn(II)-phthalocyanine and Sn(IV)-etiopurpurin among rabbit plasma proteins | Q67593139 |
| | Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells | Q68032753 |
| | Biological activities of phthalocyanines--VIII. Cellular distribution in V-79 Chinese hamster cells and phototoxicity of selectively sulfonated aluminum phthalocyanines | Q68270762 |
| | The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution | Q68672307 |
| | Photosensitization of Chinese hamster cells by water-soluble phthalocyanines | Q69600809 |
| | The phthalocyanines: a new class of mammalian cells photosensitizers with a potential for cancer phototherapy | Q69866406 |
| | The effect of different liposomal formulations on the interaction of Zn(II)-phthalocyanine with isolated low and high density lipoproteins | Q70952016 |
| | Liposome-mediated delivery of photosensitizers: localization of zinc (II)-phthalocyanine within implanted tumors after intravenous administration | Q71074685 |
| | PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours | Q71573974 |
| | Photodynamic therapeutics: basic principles and clinical applications | Q73102562 |
| | Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements | Q73254417 |
| | Eradication of multiple myeloma and breast cancer cells by TH9402-mediated photodynamic therapy: implication for clinical ex vivo purging of autologous stem cell transplants | Q73350152 |
| | Measurement of the penetration depths of red and near infrared light in human "ex vivo" tissues | Q73387609 |
| | Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs | Q73423000 |
| | Photodynamic activities and biodistribution of fluorinated zinc phthalocyanine derivatives in the murine EMT-6 tumour model | Q73503264 |
| | Tumour-localizing and tumour-photosensitizing properties of zinc(II)-octapentyl-phthalocyanine | Q73577743 |
| | Fluorescence pharmacokinetics of Lutetium Texaphyrin (PCI-0123, Lu-Tex) in the skin and in healthy and tumoral hamster cheek-pouch mucosa | Q73945710 |
| | Photosensitization of cells with different metastatic potentials by liposome-delivered Zn(II)-phthalocyanine | Q74141983 |
| | Efficacy and mechanism of aluminium phthalocyanine and its sulphonated derivatives mediated photodynamic therapy on murine tumours | Q74202090 |
| | [The optimization of a plan for the photodynamic therapy of sarcoma M1 using photosens] | Q74282225 |
| | A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice | Q74383939 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neoplasm | Q1216998 |
| | photochemotherapy | Q1428072 |
| | radiosensitizer | Q2126468 |
| | indoles | Q55698578 |
| P304 | page(s) | 98-144 | |
| P577 | publication date | 2011-12-23 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Like a bolt from the blue: phthalocyanines in biomedical optics | |
| P478 | volume | 17 | |